Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Open Label Study With OHR/AVR118 in Anorectic Patients With Recurrent or Advanced Malignancies

NCT01206335 is registered in ClinicalTrials.gov with Ohr Pharmaceutical Inc. as lead sponsor.

NCT NCT01206335
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01206335 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Open Label Study With OHR/AVR118 in Anorectic Patients With Recurrent or Advanced Malignancies
Lead sponsor
Ohr Pharmaceutical Inc.
Phase
Phase 2
Overall status
Unknown status
Start date
September 30, 2010
Completion date
February 28, 2013
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anorexia, cancer cachexia